Stockscreener 앱 받기
2.90
4.69%
0.13
전일 마감가:
$2.77
열려 있는:
$2.8
하루 거래량:
106.15K
Relative Volume:
0.84
시가총액:
$83.54M
수익:
$40,000
순이익/손실:
$-38.64M
주가수익비율:
-1.5749
EPS:
-1.8414
순현금흐름:
$-22.21M
1주 성능:
+9.02%
1개월 성능:
-12.91%
6개월 성능:
-43.47%
1년 성능:
-69.38%
1일 변동 폭
$2.7501
$2.96
1주일 범위
$2.66
$2.96
52주 변동 폭
$2.501
$12.00
Neonc Technologies Holdings Inc Stock (NTHI) Company Profile
명칭
Neonc Technologies Holdings Inc
전화
310 663 7831
주소
23975 PARK SORRENTO, CALABASAS
Compare NTHI vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTHI
Neonc Technologies Holdings Inc
|
2.90 | 83.54M | 40,000 | -38.64M | -22.21M | -1.8414 |
VRTX
Vertex Pharmaceuticals Inc
|
524.52 | 132.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
245.81 | 98.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
805.67 | 82.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
890.05 | 55.97B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
386.46 | 43.72B | 5.76B | 514.49M | 1.10B | 4.4813 |
Neonc Technologies Holdings Inc Stock (NTHI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-09-24 | 개시 | Roth Capital | Buy |
| 2026-05-19 | 개시 | Alliance Global Partners | Buy |
| 2026-05-18 | 개시 | Maxim Group | Buy |
| 2026-04-24 | 개시 | BTIG Research | Buy |
Neonc Technologies Holdings Inc 주식(NTHI)의 최신 뉴스
NeOnc Technologies Holdings, Inc. (NTHI) stock price, news, quote and history - Yahoo Finance UK
NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi - GlobeNewswire Inc.
Two Abu Dhabi children are receiving an investigational brain cancer treatment; a third is expected to join this week. - Stock Titan
NeOnc Technologies Appoints Ali Alabedin to Its Board of Directors - GlobeNewswire Inc.
NeOnc Technologies Announces FDA Meeting on November 17, 2026, for NEO212 Progress - Kalkine Media
Neonc Technologies CFO Garnett sells $16,809 stock By Investing.com - Investing.com Nigeria
Form 4 Neonc Technologies Holdings Inc For: 27 September By Investing.com - Investing.com Canada
Form 4 Neonc Technologies Holdings Inc For: 27 September - Investing.com India
Form 4 Neonc Technologies Holdings Inc For: 27 September By Investing.com - Investing.com Nigeria
Form 4 Neonc Technologies Holdings Inc For: 27 September By Investing.com - Investing.com Australia
Neonc Technologies CFO Garnett sells $16,809 stock - Investing.com
Form 4 Neonc Technologies Holdings Inc For: 27 September By Investing.com - Investing.com UK
Neonc Technologies CFO Garnett sells $16,809 stock By Investing.com - Investing.com UK
NeOnc’s Delivery may Finally Change the Equation for Brain Cancer’s Next Frontier - GlobeNewswire Inc.
[8-K] NEONC TECHNOLOGIES HOLDINGS, INC. Reports Material Event - Stock Titan
NeOnc Charting New Nasal Route to Treating Brain Cancer - GlobeNewswire Inc.
Neonc Technologies CFO sells $16,809 in company stock - Investing.com
NeOnc Technologies (NTHI) CFO sells shares under preset plan - Stock Titan
NeOnc Technologies Redeems All Outstanding Series A Convertible Preferred Stock and Eliminates Related Potential Dilution - Yahoo Finance
A $6 million payment kept NeOnc from issuing new shares - Stock Titan
NeOnc leaders (NTHI) keep buying after positive Phase 2a data - Stock Titan
NeOnc Executives Invest Approximately $629,000 in Open-Market Stock Purchases Following Positive NEO100 Phase 2a Results - TradingView
Neonc technologies CEO Thomas Chen buys $39,999 in stock - Investing.com
Neonc technologies CEO Amir Heshmatpour acquires $174,795 in stock - Investing.com
NeOnc Technologies (NTHI) CEO is buying more of his own stock - Stock Titan
NeOnc Technologies (NTHI) CFO adds shares in open-market buy - Stock Titan
NeOnc (NTHI) CEO adds shares in IRA trades - Stock Titan
NeOnc Technologies (NTHI) insider may sell $18,900 in stock - Stock Titan
48.9% had no cancer progression at six months in NeOnc’s 24-person study - Stock Titan
Neonc Technologies CEO Amir Heshmatpour buys $135,619 in shares - Investing.com
NeOnc (NTHI) CEO now holds 3.13M shares after stock buy - Stock Titan
Neonc Technologies Holdings, Briacell Therapeutics and Oncolytics Biotech Have Report Clinical and Regulatory Developments Across Brain, Breast and Colorectal Cancer - marketscreener.com
NeOnc Technologies Announces $15 Million Registered Direct Offering - The Globe and Mail
NeOnc Technologies Announces $15 Million Registered Direct Offering - The Globe and Mail
Form 8K Neonc Technologies Holdings Inc For: 10 September By Investing.com - Investing.com Nigeria
NeOnc raises USD 15m to advance Phase II CNS cancer programs after NEO100 efficacy readout - AllSci
Form 8K Neonc Technologies Holdings Inc For: 10 September By Investing.com - Investing.com India
Form 8K Neonc Technologies Holdings Inc For: 10 September By Investing.com - Investing.com Canada
Form 8K Neonc Technologies Holdings Inc For: 10 September By Investing.com - Investing.com UK
NeOnc Technologies Launches $15 Million Registered Direct Offering at $4.20 With Warrants - TradingView
NeOnc Technologies Company Profile & Introduction - Moomoo
NeOnc Technologies Holdings Secures $15 Million Registered Direct Offering After Positive Phase 2a Data and Insider Buying - Quiver Quantitative
NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data - marketscreener.com
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors - Stocktwits
NeOnc Technologies prices $15M registered direct offering - investing.com
NeOnc Technologies prices $15M registered direct offering By Investing.com - Investing.com Canada
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 - GlobeNewswire
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors - Yahoo Finance
Cancer-drug developer NeOnc plans a stock sale of about $15 million - Stock Titan
In a brain-cancer trial, 48.9% had no worsening at six months. NeOnc also redeemed $6M in stock. - Stock Titan
Neonc Technologies Holdings Inc (NTHI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Neonc Technologies Holdings Inc 주식 (NTHI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| KEITHLY GARNETT | Officer |
Sep 15 '26 |
Proposed Sale |
3.78 |
5,000 |
18,900 |
0 |
| Heshmatpour Amir F | CEO, President |
Sep 14 '26 |
Buy |
3.96 |
15,000 |
59,400 |
3,148,000 |
| CHEN THOMAS C | CEO |
Sep 14 '26 |
Buy |
3.81 |
5,242 |
19,998 |
24,503 |
| GARNETT KEITHLY | CFO |
Sep 14 '26 |
Buy |
3.89 |
257 |
1,001 |
242,357 |
| CHEN THOMAS C | CEO |
Sep 11 '26 |
Buy |
3.60 |
5,556 |
20,002 |
19,261 |
| Heshmatpour Amir F | CEO, President |
Sep 11 '26 |
Buy |
3.67 |
37,000 |
135,620 |
3,133,000 |
| CHEN THOMAS C | CEO |
Aug 18 '26 |
Buy |
5.49 |
12,757 |
69,998 |
13,705 |
| Heshmatpour Amir F | CEO, President |
Aug 18 '26 |
Buy |
5.54 |
9,000 |
49,860 |
3,096,000 |
| CHEN THOMAS C | CEO |
Aug 17 '26 |
Buy |
4.04 |
2,472 |
9,998 |
583,531 |
| Heshmatpour Amir F | CEO, President |
Aug 17 '26 |
Buy |
4.37 |
3,000 |
13,120 |
3,087,000 |
4.38%
1.00%
자본화:
|
볼륨(24시간):